MarketsStocksGLAND
GL

Gland Pharma Ltd

NSE: GLANDBSE: 543245Healthcare
Download Research Report7-page PDF
2,246.00
-1.19%
NSE · auto-updates while market open
Prev Close
₹1,642.00
Day High
₹2,336.00
Day Low
₹2,237.00
Mkt Cap
₹37,133 Cr
P / E
36.1
P / B
3.6
ROE
10.5%
52W High
₹2,396.00
52W Low
₹1,573.60
Key Metrics
Market Cap
₹37,133 Cr
P / E
36.14
P / B
3.59
EV / EBITDA
21.39
ROCE
15.0%
ROE
10.5%
Debt / Equity
0.02
Book Value
₹628.67
EPS
₹62.35
Div Yield
1.6%
Face Value
₹1
Promoter Holding
51.8%
Revenue · ₹ Cr
3.5k
FY21
4.4k
FY22
3.6k
FY23
5.7k
FY24
5.6k
FY25
6.4k
FY26
Net Profit · ₹ Cr
997
FY21
1.2k
FY22
781
FY23
772
FY24
699
FY25
1.0k
FY26
EPS · ₹ per share
₹63.1
FY21
₹73.8
FY22
₹47.4
FY23
₹46.9
FY24
₹42.4
FY25
₹62.4
FY26
P / E Ratio · price ÷ TTM EPS
1434547384390-6Jun 21Feb 23Oct 24Jun 26
P/E 36.0×Median 38.5×TTM EPS
Q1 2026 snapshot
Sales
₹1.85K Cr
Operating profit
-
OPM
-
Net profit
₹367 Cr
EPS
₹22.26
Scorecard · 7 axes
Quality
Avg
54/100
Valuation
Avg
36.1×
Growth
Weak
+3.0%
Profitability
Avg
12.7%
Performance
Good
+39.1%
Entry Point
Weak
94%
Red Flags
Strong
0 flags
Shareholding Pattern
51.8%Promoter
Promoter51.8%
FII7.3%
DII33.4%
Public7.5%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue1,384.0521,468.941,563.151,571.041,758.541,854.26
Net Profit204.692186.541215.482183.684261.475366.675
NPM %14.8%12.7%13.8%11.7%14.9%19.8%
AlertPre-trade